Stockscreener 앱 받기
0.837
1.73%
-0.0147
시간 외 거래:
.82
-0.017
-2.03%
전일 마감가:
$0.8517
열려 있는:
$0.8499
하루 거래량:
72,867
Relative Volume:
0.03
시가총액:
$1.72M
수익:
$4.76M
순이익/손실:
$-9.32M
주가수익비율:
-0.1464
EPS:
-5.7182
순현금흐름:
$-4.25M
1주 성능:
-7.35%
1개월 성능:
-12.41%
6개월 성능:
-77.97%
1년 성능:
-83.19%
1일 변동 폭
$0.7933
$0.8499
1주일 범위
$0.7651
$1.94
52주 변동 폭
$0.7651
$6.71
아카디아 바이오사이언시스 Stock (RKDA) Company Profile
명칭
Arcadia Biosciences Inc
전화
214-974-8921
주소
5956 SHERRY LANE, DALLAS, CA
Compare RKDA vs JBS, KHC, GIS, HRL, MKC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
0.837 | 1.89M | 4.76M | -9.32M | -4.25M | -5.7182 |
JBS
Jbs Nv
|
12.22 | 40.09B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
23.20 | 28.45B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
33.36 | 18.29B | 18.37B | 2.22B | 1.65B | 4.0676 |
HRL
Hormel Foods Corp
|
24.33 | 13.53B | 12.22B | 466.64M | 692.94M | 0.8477 |
MKC
Mccormick Co Inc
|
46.49 | 12.87B | 7.11B | 1.65B | 680.40M | 6.1005 |
아카디아 바이오사이언시스 Stock (RKDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-12 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | 개시 | Credit Suisse | Outperform |
| 2015-06-09 | 개시 | Piper Jaffray | Overweight |
아카디아 바이오사이언시스 주식(RKDA)의 최신 뉴스
Arcadia Biosciences Announces $4 Million Private Placement - TipRanks
Arcadia Biosciences Raises ~$4 Million in Private Placement of Pre-Funded Warrants and Options - TradingView
Arcadia Biosciences (RKDA) completes $4M private placement with warrants and options - Stock Titan
RKDA Q3 2025 Earnings: Surprise Profit Beats Estimates by Wide MarginDownward Estimate Revision - newsline.com
Arcadia Biosciences closes $4 million private placement - Investing.com
Arcadia Biosciences closes $4 million private placement By Investing.com - Investing.com South Africa
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options - Quiver Quantitative
Arcadia Biosciences raises $4M in at-the-market stock deal - Stock Titan
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces Closing of $4 Million - GlobeNewswire
MSN Money - MSN
RKDA News | ARCADIA BIOSCIENCES INC (NASDAQ:RKDA) - ChartMill
Arcadia Biosciences Raises $4 Million in Private Placement - marketscreener.com
What Does Arcadia Biosciences' Latest $4 Million Private Placement Entail - Kavout
Wellness products maker Arcadia Biosciences lines up $4M in funding - Stock Titan
Arcadia Biosciences (RKDA) Secures Funding with New Share Agreem - GuruFocus
Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million - Quiver Quantitative
Arcadia Biosciences raises $4 million in private placement - Investing.com
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire Inc.
Arcadia Biosciences, Inc. announced that it has received $3.999613 million in funding - marketscreener.com
Arcadia Biosciences (RKDA) jumps 44.5% amid heavy volume, with no clear new headline catalyst - Quiver Quantitative
RKDA Stock Whipsaws As Traders Focus On Cash, Chart - StocksToTrade
RKDA Stock Slides As Volatile Chart Tests Day Traders - timothysykes.com
RKDA Q3 2025 Earnings: EPS Surge Beats Estimates Amid No Revenue DisclosureEarnings Volatility Report - newsline.com
Arcadia Biosciences (RKDA) Slips 1.89% as Stock Tests Key Support Near $0.86Golden Cross - newsline.com
RKDA Q3 2025 Earnings: Positive EPS Surprise Amidst Revenue ChallengesCore Business Growth - newsline.com
RKDA Stock Price, Quote & Chart - ChartMill
RKDA Q3 2025 Earnings: Surprise Profitability Without Reported RevenueEarnings Revision Upgrade - newsline.com
Arcadia Biosciences (RKDA) Slides to $0.95: Support Test on the HorizonIV Percentile - newsline.com
Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash - Bez Kabli
Arcadia Biosciences (RKDA) Shows Modest Uptick Amid Consolidation Near Key LevelsChange of Character - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Profit Surges Past Wall Street TargetsFinancial Health Score - The Legal Advocate
RKDA Q3 2025 Earnings: Stunning EPS Surprise Driven by Non-Recurring Items, Stock RalliesProduct Revenue Analysis - newsline.com
RKDA Q3 2025 Earnings: Arcadia Biosciences Posts Surprise Profit as EPS Smashes EstimatesRising Community Picks - Newser
RKDA Stock Pops On Volume As Traders Hunt Volatility - StocksToTrade
RKDA Stock Slides As Traders Weigh Cash Runway And Charts - timothysykes.com
Arcadia Biosciences (RKDA) Rallies +27.91% as Bulls Target $1.29 2026-05-20Technical Analysis - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Beat: Revenue $N/A, EPS Exceeds by SignificantDividend Growth Analysis - The Legal Advocate
Armistice Capital (RKDA) reports 159,390 shares, 7.75% stake - Stock Titan
Arcadia Biosciences (RKDA) Delivers Q3 2025 Beat — EPS $0.62 vs $-0.55 ExpectedRevenue Guidance - newser.com
Arcadia Biosciences: Q1 Earnings Snapshot - KTVB
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights - The Manila Times
RKDA: Zola volumes rose 18% but net loss widened to $4.4M on lower revenue and one-time charges - TradingView
Arcadia Biosciences | 10-Q: Q1 2026 Earnings Report - Moomoo
Arcadia Biosciences (RKDA) Q1 2026 loss deepens amid going concern risk - Stock Titan
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[8-K] Arcadia Biosciences, Inc. Reports Material Event - Stock Titan
Arcadia Biosciences stock (US03020Q1058): Recent price volatility draws attention - AD HOC NEWS
TradingKey - TradingKey
아카디아 바이오사이언시스 (RKDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.54%
자본화:
|
볼륨(24시간):